Conference program

Program of the 8th AMR Conference

Pre-conference meetings
Tuesday, 5 March 2024

Conference Day 1
Wednesday, 6 March 2024

Conference Day 2
Thursday, 7 March 2024

Pre-conference meetings

Tuesday, 5 March 2024 | Venue tbd

The pre-conference meetings are not an integral part of the AMR Conference. However, when registering for the conference, you can indicate your interest to participate. The organizers will inform you about the acceptance of your participation shortly before the conference.

09:30 – 15:30

Workshop – Phage Therapy: What’s New and What’s Next?

This interactive workshop aims to delve into the development of a sustainable phage therapy value chain, emphasizing the progress, challenges and opportunities in phage therapy. Sessions will be held on scientific developments, clinical research, and phage manufacturing. Participants will also explore intellectual property strategies and engage in discussions about the global regulatory landscape. In addition, the event will include start-up showcases and an investor panel to discuss funding options and investment strategies. The workshop provides a platform for experts, entrepreneurs, and investors to explore the future of phage therapy. Number of participants will be limited.

Organized by

16:00 – 18:00

Networking meeting

Organized by

Conference Day 1

Wednesday, 6 March 2024 | Congress Center Hall 4.0

09:00 – 11:00

BEAM Alliance General Assembly

open only to members of the BEAM Alliance

09:30 – 11:00

Pre-conference workshop

Jointly organized by

More information to be released soon

11:30 – 13:00

Opening plenary

How can we combat AMR globally?

Moderator:
Marc Gitzinger (BioVersys & BEAM Alliance)

Speakers:
will be announced soon

13:00 – 14:00

Lunch break

14:00 – 15:30

Parallel sessions

Taking actions on pull incentives

Moderator:
Kevin Outterson (CARB-X & Boston University)

Speakers:
will be announced soon

Preclinical models to optimize translation to human

Moderator:
Martin Everett (Aurobac Therapeutics)

Speakers:
will be announced soon

Vaccines to keep AMR at bay

Moderator:
tba

Speakers:
will be announced soon

16:00 – 17:30

Parallel sessions

Meaningful clinical trials: combining regulatory and clinical differentiation needs

Moderator:
Glenn Dale (BioVersys)

Speakers:
will be announced soon

Novel disruptive approaches to fight AMR

Hosted by

Moderator:
Christoph Dehio (NCCR AntiResist & University of Basel)

Speakers:
will be announced soon

Roundtable: How to build bridges between human and animal health?

Moderator:
Ralf Sudbrak (Global AMR R&D Hub)

Speakers:
will be announced soon

18:00 – 19:30

Start-up pitch

Hosted by

Pitching companies to be announced

19:30 – 21:30

Evening reception

Conference Day 2

Thursday, 7 March 2024 | Congress Center Hall 4.0

08:30 – 09:30

Plenary session

A phage cocktail for breakfast?

Moderator:
Valeria Gigante (WHO)

Speakers:
will be announced soon

10:00 – 11:30

Parallel sessions

Tuberculosis: new tools against an old enemy

Moderator:
Jacqueline Huh (STOP TB Partnership)

Speakers:
will be announced soon

New tricks to combat fungal infections

Moderator:
Mark Jones (Basilea)

Speakers:
will be announced soon

Making the case for investing in AMR R&D

Moderator:
Marie Petit (Villiger Valuation)

Speakers:
will be announced soon

11:30 – 13:00

Lunch break

13:00 – 14:30

Parallel sessions

Fast, reliable and cost-effective diagnostics

Hosted by Moderator:
Jens Hellwage (InfectoGonstics)

Speakers:
will be announced soon

Push funding: a lifeline for R&D

Moderator:
Remko van Leeuwen (SurvivX)

Speakers:
will be announced soon

Technology update

Moderator:
tba

Speakers:
will be announced soon

15:00 – 16:30

Parallel sessions

Leveraging the power of diagnostics in clinical practice

Moderator:
Till Bachmann (University of Edinburgh)

Speakers:
will be announced soon

Greatest reach to the greatest need

Moderator:
Jennifer Cohn (GARDP)

Speakers:
will be announced soon

The true value of antimicrobial products

Moderator:
Deepali Patel (AMR Action Fund)

Speakers:
will be announced soon

17:00 – 18:00

Closing plenary

Future threats: Making the invisible visible

Moderator:
Florence Séjourné (Aurobac Therapeutics)

Speakers:
will be announced soon

18:00 – 19:00

Farewell reception

BEAM Alliance program committee

Marc Gitzinger

CEO, BioVersys AG & President, BEAM Alliance

Florence Séjourné

CEO, Aurobac Therapeutics & Treasurer, BEAM Alliance

Deepali Patel

Director of international policy, AMR Action Fund